Tremor
TrialsCompanies

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

PrivacyTerms

ARTV

Artiva Biotherapeutics, Inc.

Tremor tracks 1 of its cancer trials.

Company-wide warning signs

These add points to every one of this company's trials.

  • Announced layoffs or restructuringSince Oct 27, 2026+13.4
  • 4 insiders sold shares within a monthSince Nov 2, 2026+9.5

Trials

  • ARTVArtiva Biotherapeutics, Inc.
    33Calm

    AB-101 as Monotherapy and With Immunotherapy in Patients With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

    FinishedPhase 1/245 patientsMain results: Oct 6, 2025

Key executives leaving

From the last 12 months of the company's SEC reports.

None found.

Insider trades (last 6 months)

“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.

21 sales (17 not pre-planned) · 22 purchases

  • Horan ChristopherChief Tech Operations Officer · Nov 2, 2026Sold 10,423 sharesabout $44 thousand · not pre-planned
  • Bush JenniferCOO, CLO, Compliance Officer · Nov 2, 2026Sold 8,439 sharesabout $35 thousand · not pre-planned
  • Banerjee SubhashisChief Medical Officer · Nov 2, 2026Sold 1,110 sharesabout $5 thousand · not pre-planned
  • Aslan FredChief Executive Officer · Nov 2, 2026Sold 62,178 sharesabout $260 thousand · not pre-planned
  • Aslan FredChief Executive Officer · Oct 6, 2026Sold 23,463 sharesabout $169 thousand · pre-planned
  • Horan ChristopherChief Tech Operations Officer · Oct 5, 2026Sold 10,340 sharesabout $71 thousand · not pre-planned
  • Bush JenniferCOO, CLO, Compliance Officer · Oct 5, 2026

Recent SEC filings

Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.

  • Shared quarterly results; Layoffs or restructuring costsNews report (8-K)Oct 27, 2026
  • An executive or board member joined or leftNews report (8-K)Sep 11, 2026
  • Permission to sell new sharesPermission to sell new shares (S-3)Aug 6, 2026
  • Quarterly reportQuarterly report (10-Q)Aug 6, 2026
  • Shared quarterly resultsNews report (8-K)Aug 6, 2026

Money left

Coming soon: how many months of cash the company has, from its quarterly reports.
Sold 8,370 sharesabout $57 thousand · not pre-planned
  • Banerjee SubhashisChief Medical Officer · Oct 5, 2026Sold 1,099 sharesabout $8 thousand · not pre-planned
  • Aslan FredChief Executive Officer · Oct 5, 2026Sold 61,696 sharesabout $422 thousand · not pre-planned
  • Aslan FredChief Executive Officer · Sep 8, 2026Sold 23,429 sharesabout $256 thousand · pre-planned
  • Horan ChristopherChief Tech Operations Officer · Sep 3, 2026Sold 10,366 sharesabout $116 thousand · not pre-planned
  • Bush JenniferCOO, CLO, Compliance Officer · Sep 3, 2026Sold 8,391 sharesabout $94 thousand · not pre-planned
  • Banerjee SubhashisChief Medical Officer · Sep 3, 2026Sold 1,100 sharesabout $12 thousand · not pre-planned
  • Aslan FredChief Executive Officer · Sep 3, 2026Sold 61,888 sharesabout $690 thousand · not pre-planned
  • Banerjee SubhashisChief Medical Officer · Aug 27, 2026Sold 8,222 sharesabout $99 thousand · pre-planned
  • Banerjee SubhashisChief Medical Officer · Aug 18, 2026Sold 429 sharesabout $5 thousand · pre-planned
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 31, 2026Bought 24,944 sharesabout $248 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 29, 2026Bought 20,824 sharesabout $208 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 24, 2026Bought 41,319 sharesabout $413 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 23, 2026Bought 59,880 sharesabout $596 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 22, 2026Bought 84,124 sharesabout $835 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 21, 2026Bought 120,582 sharesabout $1.2 million ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 17, 2026Bought 7,882 sharesabout $71 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 16, 2026Bought 152,472 sharesabout $1.4 million ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 13, 2026Bought 6,522 sharesabout $58 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 13, 2026Bought 6,552 sharesabout $59 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jul 10, 2026Bought 15,102 sharesabout $135 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jun 26, 2026Bought 1,876 sharesabout $17 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jun 25, 2026Bought 31,000 sharesabout $275 thousand ·
  • RA CAPITAL MANAGEMENT, L.P.Board member · Jun 16, 2026Bought 124,893 sharesabout $1.1 million ·

    • Showing the 30 most recent.

    Other newsNews report (8-K)
    Jul 22, 2026
  • An executive or board member joined or leftNews report (8-K)May 19, 2026